1st Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

Firm
Client
Income
—
Expenses
$390,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to trade and tariffs

LobbyistCovered position, as disclosed
ADAM LOTSPIKE —
TODD SPANGLER —
ELIZABETH WOODY —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response

LobbyistCovered position, as disclosed
TEGAN GELFAND New —
JESSICA JOHNSTON —
RITA LIVADAS New —
ADAM LOTSPIKE —
TODD SPANGLER —
ELIZABETH WOODY —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Bills named: S. 3404 (116th), H.R. 748 (116th), H.R. 4100 (116th), H.R. 2064 (116th)

Veterans VET

Issues related to Veterans Affairs procurement of medical devices

LobbyistCovered position, as disclosed
ADAM LOTSPIKE —
TODD SPANGLER —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.